AUS
NZ
UK
CA
USA
IND
Highlights
- Healthtech companies have a major focus on medical devices, IT systems, artificial intelligence (AI), cloud, and blockchain for medical use.
- Products of Jayex Technology include Jayex Connect, a cloud-based patient engagement platform, and Enlighten, a patient workflow platform.
- In FY22, Artrya Limited is focusing on developing medical technology using artificial intelligence.
The S&P/ASX200 was trading in red today (31 August), falling 13.10 points or 0.19% to 6,985.20 at 2:23 PM AEST. However, the benchmark of healthcare sector, S&P/ASX200 HealthCare was trading in green today with a gain of 0.05% at the same time Similarly, the index’s month to date price percent change also remains positive at 0.30% (31 Aug, 2:23 PM AEST).
In this article, we at © Kalkine Media® will discuss five ASX-listed healthcare stocks specialising in providing technology services. These stocks belong to companies with a major focus on medical devices, IT systems, artificial intelligence (AI), cloud and blockchain for medical use.
Jayex Technology Ltd (ASX:JTL)
Jayex Technology has developed healthcare technology platforms and it dispenses automation systems for the healthcare and pharma sectors. The company’s products include Jayex Connect, a cloud-based patient engagement platform, and Enlighten, a patient workflow platform.
In August 2022, the company published its report for the half year ended 30 June 2022. It reported a 13.3% increment in revenues from ordinary activites. However, the company incurred a net loss of AU$1.1million during the period.
Oakridge International Ltd (ASX:OAK)
Oakridge International is primarily involved in selling professional healthcare technology equipment and solutions to healthcare facilities.
During FY22, the Internet of things (IoT) and healthcare technology company reported a 68% decline in revenue from ordinary activities. The company attributes the decline in revenue to the recognition of R&D tax concession of AU$881,270 in the prior year compared to AU$131,501 in the current year.
Global Health Ltd (ASX:GLH)
Global Health Limited offers digital health solutions to health businesses for delivering efficient patient care. Based in Australia, the company offers different kinds of customised software and software-as-a-service (SaaS) solutions to the healthcare sector.
In the first week of August, Global Health inked an important deal with Latrobe Community Health. This is a substantial contract for Global Health, following on from the robust momentum developed in FY21 and setting a solid target for FY22.
Singular Health Group Ltd (ASX:SHG)
Singular Health Group, a medical technology company, offers personalised surgical planning solutions to help patients and practitioners drive health outcomes.
Recently, the company submitted a 510(k) premarket notification to the United States Food & Drug Administration (FDA) for 3Dicom MDTM collaborative DICOM viewer software. The software is designed for medical practitioners and radiologists to view Digital Imaging, and Communication in Medicine (DICOM) scans.
Artrya Ltd (ASX:AYA)
Artrya Limited is an applied artificial intelligence (AI) healthcare company which uses deep learning algorithms to enhance the diagnosis of coronary heart disease and develops an overview of a patient at risk.
In its annual report for FY22, Artrya reported a net loss of AU$ 17,155,000. During the financial year, the company remained focused on developing medical technology using artificial intelligence to identify patients at risk of coronary artery disease more accurately.
